GAK and Parkinson disease: Nonsynonymous variants in LRRK2 resulting in amino acid substitutions at positions 2019 and 1441 in the ROC/COR and kinase domains are known to cause LOPD, while regulatory variants of GAK have been shown to modulate PD risk across multiple ethnicities (9, 10).